Brief: Medicinova Says Genzyme Filed First Amended Complaint, Which Included Claim For Infringement Of A U.S. Patent, In A Lawsuit Previously Filed Against Novartis

Medicinova

05/04/2022 11:19

April 5 (Reuters) - MediciNova Inc  MNOV.O :
    * MEDICINOVA - GENZYME FILED FIRST AMENDED COMPLAINT, WHICH
INCLUDED CLAIM FOR INFRINGEMENT OF A U.S. PATENT, IN A LAWSUIT
PREVIOUSLY FILED AGAINST NOVARTIS
    * MEDICINOVA - IF GENZYME RECOVERS ANY MONETARY DAMAGES AS A
RESULT OF LITIGATION, THEN CO MAY BE ENTITLED TO RECEIVE A
CERTAIN PORTION OF SUCH DAMAGES

Source: [ID: https://bit.ly/3r3jzuH]
Further company coverage:  MNOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))